Sensible Biotechnologies, Inc.
Biotechnology company · Claymont, Delaware, United States
Sensible Biotechnologies, Inc. is a biotechnology company headquartered in Claymont, Delaware, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $1.8 million sold in a notice filed in 2023.
Sensible Biotechnologies at a glance
What does Sensible Biotechnologies do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.8 million sold (2023).
Frequently asked questions about Sensible Biotechnologies
Where is Sensible Biotechnologies headquartered?
Sensible Biotechnologies, Inc. is headquartered in Claymont, Delaware, United States.
What does Sensible Biotechnologies do?
Sensible Biotechnologies, Inc. is a biotechnology company.
When was Sensible Biotechnologies founded?
The earliest incorporation on record for Sensible Biotechnologies, Inc. is in 2021, according to public company registers.
Similar companies
- Converge Bio Inc.Claymont, Delaware, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences